Author

W Zhouwen

Institution: AbbVie (United States)

Observed institution: AbbVie (United States)

OpenAlex ID: A5000178432

A145 Efficacy and Safety of Upadacitinib Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Results From a Randomized Phase 3 Study

2022 · R Panaccione, S Danese, et al. · Journal of the Canadian Association of Gastroenterology · 3

Works count: 1

Citation count: 3

H-index: 1

I10-index: